4-[(3-Chloropropyl)sulfonyl]morpholine → HCID 178508203, 화합물

HRID 536262노트

반응식

HRID 536262 반응식
Br.[CH3:2][O:3][C:4]1[CH:5]=[CH:6][C:7]2[C:8]3[N:9]([CH2:15][CH2:16][N:17]=3)[C:10]([NH2:14])=[N:11][C:12]=2[CH:13]=1.ClC[CH2:20][CH2:21][S:22]([N:25]1[CH2:30][CH2:29][O:28][CH2:27][CH2:26]1)(=[O:24])=[O:23]>>[N:25]1([S:22]([CH2:21][CH2:20][CH2:2][O:3][C:4]2[CH:5]=[CH:6][C:7]3[C:8]4[N:9]([CH2:15][CH2:16][N:17]=4)[C:10]([NH2:14])=[N:11][C:12]=3[CH:13]=2)(=[O:24])=[O:23])[CH2:26][CH2:27][O:28][CH2:29][CH2:30]1

참가 물질

3

실험 절차

The procedure used for the preparation of Example 24, Step 2 was used to prepare the title compound from 5-amino-2,3-dihydroimidazo[1,2-c]quinazolin-8-ol (Intermediate I) and 4-[(3-chloropropyl)sulfonyl]morpholine (Intermediate E). Yield 190 mg (61%). Rf=0.68 in 10% MeOH/CH2Cl2, HPLC MS RT=1.13 min, MH+=394.4.

후처리

  1. customThe procedure used for the preparation of Example 24, Step 2

출처 및 근거

ORD 기록
ord-c3df135775ee41428495ce412037b458
출처 데이터셋
uspto-grants-2014_10
특허 번호
US08859572B2

반응 노트

불러오는 중…